(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

WHITELAB

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: VerbalEscritório: US

Snapshot rápido

WHITELAB

ST13

US500000098209041

Classe

42

Pedido

98209041

Registro

7701099

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

18

Atualização mais recente

25/02/2025

Classificação

Registrada

Tipo de marca

Verbal

Classes Nice

42

Data de depósito

04/10/2023

Data de registro

25/02/2025

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

25/02/2025

Última transação

25/02/2025

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

4

Tipo de titular

99

Localização do titular

Cedex, FR

Examinador

REYNOLDS,DYLAN M

Localização atual

FILE REPOSITORY (FRANCONIA)

Titulares e representantes

Titulares

W. G. (pessoa física)

Representantes

Pina Campagna CARTER, DELUCA, AND FARRELL, LLP

Classificação técnica

Classes Nice

Classe 42

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 42

Scientific research and development; Research services and development of new products for third parties; Industrial research in the field of biology; Industrial and pharmaceutical development in the field of human biology and diseases; scientific research in the field of genetics; Biological research; Technical research in the field of field of geneticsmedical devicesgenomic medicinegenetic engineeringsynthetic biologydata scienceartificial intelligence; Scientific and technical research and development in the field of geneticsmedical devicesgenetic engineeringsynthetic biologyartificial intelligence; Research and development of medical devices; engineering services in the field of genetics; Scientific research services relating to the isolation and culture of human tissues and cells; scientific and medical research and development in the field of tissue manufacturing; research in the field of regenerative biotherapiesgenomics; research and development of new products in the field of regenerative biotherapiesgenomicsbiotechnologychemicals and pharmaceuticals; scientific research and development for medical purposes; consulting services in scientific and industrial research; engineering in the medical field; design of diagnostic medical equipment and medical devices; computer-assisted diagnostic testing services for others for scientific research purposes; computer diagnostic services; designdevelopment and maintenance of software and mobile applications for use in medical technologies; conversion of data or documents from physical to electronic media; Software as a Service featuring software for use in searchingtrackingexploration and analysis of data for use in the field of pharmaceuticals and medicines in the medical field; Computer Platform as a Service featuring software for use in searchingtrackingexploration and analysis of data for use in the field of pharmaceuticals and medicines in the medical field; Biopharmaceutical and pharmaceutical research services; Scientific research related to drugsbiopharmaceuticals and pharmaceuticalspharmaceutical drugs and biopharmaceutical drugs; Research and development in the field of diagnostic preparations; Research and development services in the field of medical diagnostic tools and software design; computer software designdevelopmentinstallationupdating; electronic data storage in the field of DNA sequencing for diagnostic and therapeutic purposes; technical data analysis in the field of DNA sequencing for diagnostic and therapeutic purposes; IT consulting services relating to on-line searchable databases and algorithms for the management and delivery of scientific analysis results based on genomic data; rental and maintenance of software for searchingtrackingexploration and analysis of data for use in the field of pharmaceuticals and medicines; rental of computer hardware; rental of scientific instruments; rental of laboratory apparatus and instruments; design and development of software for use in medical technologies; development and testing of methodsalgorithmscomputer software in the field of multi-omics data including DNA and RNA sequencing; technical consulting services in the application and use of software; software engineering services for data processing programs; software engineering services; software as a service (SAAS) services featuring software platforms for use in artificial intelligenceall of the aforesaid in the field of DNA sequencingmedical diagnosticsgeneticsgenetic engineering

Publicações

Histórico de despachos e eventos da marca no USPTO.

18 publicações encontradas

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

25/02/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

25/02/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/01/2025

PUBO

PUBLISHED FOR OPPOSITION

07/01/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/01/2025

CHPB

POST PUBLICATION AMENDMENT - ENTERED

18/12/2024

APET

ASSIGNED TO PETITION STAFF

17/12/2024

PPAR

POST PUBLICATION AMENDMENT RECEIVED

13/06/2024

EPPA

TEAS POST PUBLICATION AMENDMENT RECEIVED

13/06/2024

ERRR

ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED

13/06/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/06/2024

XAEC

EXAMINER'S AMENDMENT ENTERED

06/06/2024

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

06/06/2024

GNEA

EXAMINERS AMENDMENT E-MAILED

06/06/2024

CNEA

EXAMINERS AMENDMENT -WRITTEN

06/06/2024

DOCK

ASSIGNED TO EXAMINER

23/05/2024

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

13/10/2023

NWAP

NEW APPLICATION ENTERED

07/10/2023

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace WHITELAB ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.